Avrobio Inc (AVRO)
1.22
-0.01
(-0.81%)
USD |
NASDAQ |
May 03, 16:00
1.23
+0.01
(+0.82%)
After-Hours: 20:00
Avrobio 1 Year Total Returns (Daily): 83.40% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 03, 2024 | 83.40% |
| May 02, 2024 | 88.65% |
| May 01, 2024 | 45.45% |
| April 30, 2024 | 19.19% |
| April 29, 2024 | 19.19% |
| April 26, 2024 | 35.96% |
| April 25, 2024 | 33.90% |
| April 24, 2024 | 32.21% |
| April 23, 2024 | 28.12% |
| April 22, 2024 | 27.06% |
| April 19, 2024 | 29.03% |
| April 18, 2024 | 37.17% |
| April 17, 2024 | 31.39% |
| April 16, 2024 | 33.62% |
| April 15, 2024 | 33.62% |
| April 12, 2024 | 42.70% |
| April 11, 2024 | 33.68% |
| April 10, 2024 | 37.36% |
| April 09, 2024 | 29.90% |
| April 08, 2024 | 29.90% |
| April 05, 2024 | 41.10% |
| April 04, 2024 | 39.21% |
| April 03, 2024 | 33.33% |
| April 02, 2024 | 28.00% |
| April 01, 2024 | 28.00% |
| Date | Value |
|---|---|
| March 28, 2024 | 21.90% |
| March 27, 2024 | 14.55% |
| March 26, 2024 | 29.23% |
| March 25, 2024 | 25.13% |
| March 22, 2024 | 4.06% |
| March 21, 2024 | -3.85% |
| March 20, 2024 | 4.06% |
| March 19, 2024 | 5.88% |
| March 18, 2024 | 8.40% |
| March 15, 2024 | 5.69% |
| March 14, 2024 | 4.96% |
| March 13, 2024 | 6.61% |
| March 12, 2024 | 8.47% |
| March 11, 2024 | 10.17% |
| March 08, 2024 | -6.43% |
| March 07, 2024 | -7.75% |
| March 06, 2024 | -6.29% |
| March 05, 2024 | -9.72% |
| March 04, 2024 | -9.03% |
| March 01, 2024 | -6.99% |
| February 29, 2024 | -6.43% |
| February 28, 2024 | -5.71% |
| February 27, 2024 | -8.45% |
| February 26, 2024 | -5.80% |
| February 23, 2024 | -2.29% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-92.05%
Minimum
May 02 2022
166.7%
Maximum
Oct 16 2023
-22.76%
Average
-30.33%
Median
1 Year Total Returns (Daily) Benchmarks
| Axonics Inc | 29.86% |
| Catalent Inc | 15.68% |
| AIM ImmunoTech Inc | -15.65% |
| Protalix BioTherapeutics Inc | -63.81% |
| Armata Pharmaceuticals Inc | 61.69% |